menu
    • menu

    Company profile for Valitor

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Valitor is conquering limitations of established drug targets by leveraging its multi-valent biopolymer technology to maximize benefits for patients. Valitor is initially focused on improving patient outcomes in ophthalmology and vision-threatening diseases.The company is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ValitorUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Bakar Labs 2630 Bancroft Ave Berkeley, CA 94704
    Telephone
    Telephone
    (510) 545-6062
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.valitorbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valitor To Present At 15Th Ophthalmology Innovation Summit
    Valitor To Present At 15Th Ophthalmology Innovation Summit

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191856/0/en/Valitor-Announces-Upcoming-Presentation-at-the-15th-Annual-Ophthalmology-Innovation-Summit-OIS.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Valitor Shows VLTR-559 Superiority In Wet AMD Treatment
    Valitor Shows VLTR-559 Superiority In Wet AMD Treatment

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169296/0/en/Valitor-Presents-Preclinical-Data-Demonstrating-VLTR-559-Achieves-Superior-Durability-and-Sustained-Anti-VEGF-Activity-with-a-Favorable-Safety-Profile-as-a-Treatment-for-Wet-AMD.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Valitor Appoints Biotech and Ophthalmic Veteran Gregory D. Kunst
    Valitor Appoints Biotech and Ophthalmic Veteran Gregory D. Kunst

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168769/0/en/Valitor-Appoints-Biotech-and-Ophthalmic-Industry-Veteran-Gregory-D-Kunst-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share
    Valitor To Present At Eyecelerator During AAO 2025 Meeting
    Valitor To Present At Eyecelerator During AAO 2025 Meeting

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161670/0/en/Valitor-Announces-Upcoming-Presentation-at-the-Eyecelerator-Conference-Hosted-in-Conjunction-with-the-American-Academy-of-Ophthalmology-AAO-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Valitor to Present New Data on VLTR-559 for Wet AMD at Conference
    Valitor to Present New Data on VLTR-559 for Wet AMD at Conference

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3137072/0/en/Valitor-Announces-Upcoming-Presentations-at-the-Ophthalmology-Futures-Retina-Forum-and-Euretina-Conference-Including-New-Data-for-its-Long-Acting-Anti-VEGF-Drug-Candidate-for-Wet-A.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    Valitor's VLTR-559 Triples Potency vs Aflibercept in Wet AMD
    Valitor's VLTR-559 Triples Potency vs Aflibercept in Wet AMD

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3123994/0/en/Valitor-Highlights-Three-fold-Increase-with-VLTR-559-in-Sustained-Potency-and-Durability-over-Aflibercept-in-Preclinical-Ocular-Wet-AMD-Models.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search